(Q36889164)

16 August 2017

1 reference

title

PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? (English)

1 reference

16 August 2017

Ahmed W

1

1 reference

16 August 2017

Ziouzenkova O

2

1 reference

16 August 2017

Brown J

3

1 reference

16 August 2017

Devchand P

4

1 reference

16 August 2017

Francis S

5

1 reference

16 August 2017

Kadakia M

6

1 reference

16 August 2017

Kanda T

7

1 reference

16 August 2017

Orasanu G

8

1 reference

16 August 2017

Sharlach M

9

1 reference

16 August 2017

Zandbergen F

10

1 reference

16 August 2017

Plutzky J

11

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Journal of Internal Medicine

16 August 2017

1 reference

16 August 2017

262

1 reference

16 August 2017

184-198

1 reference

16 August 2017

2

1 reference

Obesity and the regulation of energy balance

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Roles of PPARs in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Transcriptional regulation of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

The PPARs: from orphan receptors to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Retinoid x receptor heterodimers in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptors: from genes to physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Changes in attitude, changes in latitude: nuclear receptors remodeling chromatin to regulate transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Inflammation in atherosclerosis and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Targeted disruption of the peroxisome proliferator-activated receptor alpha gene, PPAR alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

PPARalpha activators inhibit tissue factor expression and activity in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

The PPARalpha-leukotriene B4 pathway to inflammation control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Effects of fenofibrate on inflammatory cytokines and blood pressure in patients with hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptors and cardiovascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Species differences in sequence and activity of the peroxisome proliferator response element (PPRE) within the acyl CoA oxidase gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Oxidized omega-3 fatty acids in fish oil inhibit leukocyte-endothelial interactions through activation of PPAR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Differential activation of adipogenesis by multiple PPAR isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

A single-base mutation in the peroxisome proliferator-activated receptor gamma4 promoter associated with altered in vitro expression and partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Lysophosphatidic acid induces neointima formation through PPARgamma activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

PPARs and the complex journey to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

PPAR gamma and human metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

PPAR gamma is required for placental, cardiac, and adipose tissue development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Genetic basis of lipodystrophies and management of metabolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Acquired and inherited lipodystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

The Pro115Gln polymorphism within the PPAR gamma2 gene has no epidemiological impact on morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

PPAR delta: a dagger in the heart of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Regulation of muscle fiber type and running endurance by PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

PPARdelta is a very low-density lipoprotein sensor in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Lipases and HDL metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Lipoprotein lipase: structure, function, regulation, and role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Lipoprotein lipase gene variants and the effect of environmental factors on cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Interactions of retinoid binding proteins and enzymes in retinoid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Oxidative modification of low-density lipoprotein (LDL) in HD patients: role in electronegative LDL formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Asymmetric cleavage of beta-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01825.X

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

10.1111/J.1365-2796.2007.01825.X

15 July 2023

Identifiers

DOI

1 reference

16 August 2017

1 reference